FDA Drug Application (090899) for VENLAFAXINE HYDROCHLORIDE by TORRENT PHARMS LLC

Back to FDA Applications sponsored by TORRENT PHARMS LLC

Application Number090899
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
DosageEQ 37.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVENLAFAXINE HYDROCHLORIDE
Active IngredientVENLAFAXINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient VENLAFAXINE HYDROCHLORIDE3


Back to FDA Applications sponsored by TORRENT PHARMS LLC